
Galera Therapeutics GRTX
Quarterly report 2026-Q1
added 05-14-2026
Galera Therapeutics PEG Ratio 2011-2026 | GRTX
Annual PEG Ratio Galera Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.0195 | - | - | - | -0.147 | -0.126 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.0195 | -0.147 | -0.0846 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
0.0115 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.156 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
0.000009 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
0.103 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.57 | - | 0.74 % | $ 768 M | ||
|
Esperion Therapeutics
ESPR
|
0.799 | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
-0.83 | $ 34.45 | 4.74 % | $ 927 M | ||
|
Midatech Pharma plc
MTP
|
-0.73 | - | -18.52 % | $ 27.3 M | ||
|
Forte Biosciences
FBRX
|
-0.00934 | $ 20.31 | 1.2 % | $ 263 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | ||
|
Grifols, S.A.
GRFS
|
-0.048 | $ 8.19 | 4.46 % | $ 5.57 B | ||
|
Celyad Oncology SA
CYAD
|
0.0181 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
0.863 | - | -7.31 % | $ 87 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 6.82 | 1.94 % | $ 187 M | ||
|
Generation Bio Co.
GBIO
|
-0.476 | - | - | $ 344 M | ||
|
IMV
IMV
|
-0.283 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-1.49 | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
0.00586 | $ 90.36 | 2.93 % | $ 21.8 B | ||
|
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.62 | -0.61 % | $ 431 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
Compugen Ltd.
CGEN
|
-0.077 | $ 2.71 | -0.92 % | $ 253 M | ||
|
Anika Therapeutics
ANIK
|
0.147 | $ 15.14 | 2.16 % | $ 217 M | ||
|
Advaxis
ADXS
|
-0.00008 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
0.00152 | - | 5.93 % | $ 314 M | ||
|
Incyte Corporation
INCY
|
0.135 | $ 97.08 | 1.55 % | $ 19 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.0406 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.39 | 4.17 % | $ 5.58 M | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
0.00516 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
-0.0207 | $ 1.51 | 2.03 % | $ 177 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-0.0646 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
6.77 | $ 20.47 | 4.97 % | $ 2.6 B | ||
|
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000175 | - | -11.43 % | $ 502 K |